Global Bone Void Fillers Market is valued at $3.5 billon (2022) and is growing at a CAGR of 6%

A bone void is a cavity in bone that results from a failure of the bone's self- healing process. Healthy bone tissue can be lost or damaged as a result of infection, trauma, tumors or orthopaedic procedures. A bone void filler/graft is a material used to fill a bone defect or a void to correct these conditions. Bony voids can be filled using autografts, allografts, and synthetic grafts.

Increasing number of bone fractures and people suffering from orthopaedic disorders set to drive the growth of bone void fillers market

As the global population ages, the number of people suffering from orthopaedic disorders is rising. In United States, 1.5 million people are diagnosed with osteoporosis each year. Further, according to International Osteoporosis Foundation, the number of osteoporotic fractures in Europe (EU27, Switzerland and the UK) would grow by 25% and reach 5.3 million in 2034 from 4.3 million in 2019. The growing number of fractures and orthopaedic population would propel the demand for bone void fillers.

Advanced market products such as antibiotics-based bone void fillers to offer new growth opportunities in Bone Void Fillers Market

Infection is a major problem after orthopaedic procedures and may lead to serious consequences. Owing to this, key players are focusing on launching bone void fillers formulated in combination with antibiotics. In June 2021, Elute, Inc. received authorization from the US FDA to use its EP Granules with Tobramycin in clinical trial. The product is a resorbable bone void filler that delivers a broad-spectrum antibiotic in a local and targeted manner in the surgical treatment of bone infections following hip or knee replacements.

Geographic Snapshot: North America leads the adoption of Bone Void Fillers Market

From a geographic perspective, North America has a major market share of global bone void fillers market. This is mainly attributed to the large number of orthopaedic procedures, growing aging population, and relatively higher penetration of bone void filling products in the region.

Competitive Landscape Analysis: Global Bone Void Fillers Market

Some leading market players operating in the global bone void filler market are Medtronic, Graftys, DePuy Synthes Companies (JnJ), Stryker, Baxter, bioventus, Orthofix, Bone Solutions Inc., Curasan, Inc., Olympus Terumo Biomaterials Corporation, Biocomposites, Arthrex, Zimmer Biomet, Collagen Matrix, Bonesupport AB, among others.

Get Customized Report on Bone Void Fillers Market @ https://meditechinsights.com/global-bone-void-fillers-market/

Comments

Post a Comment

Popular posts from this blog

Global Healthcare Companion Robots Market valued at about $3 billion (2020), is growing at a lucrative CAGR close to 20% through 2020-2025

Companion robots offer companionship and emotional support for the children, elderly, and disabled people. Over the years, the improvements in sensors, actuators, and AI have led to rise in interest in healthcare companion robots market. Rising aging population, the rising cost of elder care, and shortage of caregivers The population across the globe is aging and the number of caregivers in relation to the aging population is declining. In Japan, there will be an estimated shortage of 1 million caregivers by 2025. Moreover, the cost of elder care is also rising. Between 2019 and 2020, the cost of in-home care jumped by about 4.4%; assisted living costs surged by 6.2%; and nursing home costs increased by 3%. The use of robots instead could help reduce this cost. For instance, a monthly service contract for Stevie (a robot developed by Trinity College, Dublin) would likely run between 50-60% of the cost of hiring a human to do the same tasks, as per their claim. “The growing dispar...
Read more

Global Mycoplasma Testing Market is slated to see a lucrative growth rate of 11% by 2027

Mycoplasmas are the smallest known free-living microorganisms and are frequent contaminants of mammalian cell cultures. For the safety and purity of vaccines and other biological cell-derived products, it is crucial that the cell substrates and unprocessed bulk materials are free of adventitious agents, including mycoplasma.  In many cases, mycoplasmas vary from other forms of bacteria, making them difficult to culture and identify. Testing is done to detect mycoplasma like Mycoplasma hominis, Mycoplasma genitalium, Mycoplasma pneumoniae, and Ureaplasma urealyticum which can cause nongonococcal urethritis (NGU), prostate inflammation (prostatitis), vaginal discharge, and pelvic inflammatory disease (PID) in both men and women. Rising Concerns of Cell Culture Contamination to Trigger the Growth of the Global Mycoplasma Testing Market Mycoplasmas randomly contaminate the fluids used in the bioprocessing and cell culture. It is commonly known that primary cell cultures have a minimum...
Read more

Global Obesity Drugs Market valued at $2.3 billion in 2022, is expected to Witness a Healthy Growth of 25% by 2027

Obesity and overweight are defined as gain of additional fat thus leading to a number of diseases, which can be measured by using body mass index (BMI) as a baseline. A BMI of over 30 is generally considered as obese and a BMI of over 25 is considered as overweight. Obesity is a major risk factor to various diseases such as diabetes, heart diseases, and cancer; approximately over 650 million obese patients living across the world as as projected by World Health Organization (WHO). Rising Obese and Overweight Population to Trigger the Demand of Obesity Drugs Market Obesity is one of the topmost contributors to a number of medical diseases such as heart diseases, stroke, cancer and diabetes. World Obesity Atlas 2022 forecasted the growth of global obese population to be 16.1% in 2025, accounting for 892 million people which will further reach 1,025 million by 2030 with a healthy growth rate of 17.5% in 2030.  Some of the regional obesity burden estimated by World Obesity Atlas 202...
Read more